Fig. 5From: Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancerKnockdown of INMT amplifies the anticancer activity of selenium compounds MSA and MSC in vitro and in mouse models. A MTT analysis for the viability of INMT-KD or control Myc-CaP cells cultured in charcoal-treated medium and treated with vehicle or MSA (1 μM) for 72 h. B MTT analysis for the viability of INMT-KD or control DU145 cells cultured in normal medium and treated with vehicle or MSA (1 μM) for 72 h. C, D 1 × 106 INMT-KD or control Myc-CaP cells were inoculated s.c. into the flank of castrated FVB male mice, 5 days later followed by treatment with i.p. vehicle or 5 mg/kg MSC once a day (C). Twenty six days after cell inoculation mice were sacrificed and tumor were collected and weighted (D). E 5 × 106 INMT-KD or control DU145 cells were inoculated s.c. into the flank of RAG1−/− male mice, 5 days later mice were treated with i.p. vehicle or 5 mg/kg MSC once a day. Tumor volume was determined at indicated intervals. *, P < 0.05; **, P < 0.01; ***, P < 0.001Back to article page